CHMP5 and viral infectious disease: Our study of IgG antibodies to Spike and RBD protein accompanied by neutralizing assays against SARS-CoV-2 and determination of T cell IFN-γ responses to SARS-CoV-2 antigens identifies the presence of humoral and T cell responses that protect against viral infection.